Form 8-K - Current report:
SEC Accession No. 0000059255-23-000007
Filing Date
2023-03-06
Accepted
2023-03-06 16:20:47
Documents
15
Period of Report
2023-03-02
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vhl-20230302x8k.htm   iXBRL 8-K 51258
2 EX-14.1 vhl-20230302xex14d1.htm EX-14.1 41706
3 GRAPHIC vhl-20230302xex14d1002.jpg GRAPHIC 3601
  Complete submission text file 0000059255-23-000007.txt   316471

Data Files

Seq Description Document Type Size
4 EX-101.SCH vhl-20230302.xsd EX-101.SCH 3236
5 EX-101.LAB vhl-20230302_lab.xml EX-101.LAB 630
6 EX-101.PRE vhl-20230302_pre.xml EX-101.PRE 10661
9 EXTRACTED XBRL INSTANCE DOCUMENT vhl-20230302x8k_htm.xml XML 4778
Mailing Address THREE LINCOLN CENTER 5430 LBJ FREEWAY SUITE 1700 DALLAS TX 75240-2620
Business Address 5430 LBJ FRWY STE 1700 DALLAS TX 75240 9722331700
VALHI INC /DE/ (Filer) CIK: 0000059255 (see all company filings)

EIN.: 870110150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-05467 | Film No.: 23709199
SIC: 2810 Industrial Inorganic Chemicals